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Dysphagia is extremely common following stroke, aﬀecting 13%–94% of acute stroke suﬀerers. It is associated with respiratory
complications, increased risk of aspiration pneumonia, nutritional compromise and dehydration, and detracts from quality of
life. While many stroke survivors experience a rapid return to normal swallowing function, this does not always happen. Current
dysphagiatreatmentinAustraliafocusesuponpreventionofaspirationviadietandﬂuidmodiﬁcations,compensatorymanoeuvres
and positional changes, and exercises to rehabilitate paretic muscles. This article discusses a newer adjunctive treatment modality,
neuromuscular electrical stimulation (NMES), and reviews the available literature on its eﬃcacy as a therapy for dysphagia with
particular emphasis on its use as a treatment for dysphagia in stroke. There is a good theoretical basis to support the use of NMES
as an adjunctive therapy in dysphagia and there would appear to be a great need for further well-designed studies to accurately
determine the safety and eﬃcacy of this technique.
1.Introduction
Dysphagia (diﬃculty eating and swallowing) is extremely
common following a stroke, aﬀecting 13%–94% of acute
stroke suﬀerers, with incidence relating to lesion size and
location [1–3]. Dysphagia has been associated with higher
rates of respiratory complications and increased risk of
aspirationpneumonia[3–5],dehydration[6]andnutritional
compromise [7]. It is also a socially penalising occurrence
with a signiﬁcant impact on suﬀerers’ quality of life. While
there is a rapid return to normal function for many stroke
survivors, this is not always the case. Mann et al. found
m o r et h a nh a l fo fag r o u po fs t r o k es u r v i v o r sa d m i t t e dt o
hospital with dysphagia continued to demonstrate signs of
swallowingimpairmentonvideoﬂuoroscopywhentheywere
followed up at 6 months post stroke [8]. Dysphagia has been
associated with poorer outcomes in stroke and increased
likelihood of residential placement [7] and adds signiﬁcantly
to the estimated lifetime costs of between $12,031 and
$73,542 [9] in Australian stroke survivors.
Current treatment for dysphagia in Australia involves
prevention of aspiration in the form of diet and ﬂuid modiﬁ-
cations, compensatory manoeuvres and positional changes,
and rehabilitation exercises. This article discusses a newer
treatment modality, neuromuscular electrical stimulation
(NMES), and reviews the available literature on its eﬃcacy
as a therapy for dysphagia with a particular emphasis on its
use as a therapy for dysphagia following stroke.
2. What Is NeuromuscularElectrical
Stimulation (NMES)?
Neuromuscular electrical stimulation has been utilised by
physical therapists for several decades [10]. It allows bypass
of the injured central circuitry to activate neural tissue and
contract muscles to provide function to what is otherwise
a nonfunctioning limb or structure [11]. NMES involves
passing a small electrical current transcutaneously via elec-
trodes to stimulate the neuromuscular junction and create a
muscle contraction. It is only a viable therapeutic technique
for muscles with an intact nerve supply, but has been used
successfully on large skeletal muscles in many aetiologies,
including stroke [11]. NMES for dysphagia involves applying
electrodes to the muscles of the head and neck, and
stimulating those muscles that are weakened or hemiparetic2 Stroke Research and Treatment
using pulses of electricity. This is generally combined with
the subject swallowing food or ﬂuids that are predetermined
torepresentthemostappropriateconsistencythattheperson
can tolerate without aspiration. NMES is reported to have
beenusedtotreatBell’sPalsy[12],OpercularSyndrome[13],
Multiple Sclerosis [14], head and neck cancer [15] and voice
disorders [16], as well as stroke.
3. Reviewingthe LiteratureaboutNMES as
a Treatment in Dysphagia Therapy
The following review was based on a computer-assisted
search using the database Medline. To identify relevant
articlespublishedbetween2001and2010,thesearchstrategy
[(dysphagia) AND (neuromuscular electrical stimulation)
OR (VitalStim)] was utilised. Only articles published in
English and describing interventions with adults were
included. This search identiﬁed eighteen articles discussing
NMES published between 2001 and 2009. Of these, ﬁve
were related to dysphagia as a consequence of stroke alone
[17–21], eight to dysphagia relating to other aetiologies,
including mixed aetiologies [14, 15, 22–27], three examined
the eﬀect of NMES on the swallowing mechanism in
normal subjects [28–30], and two were related to NMES
but in the form of a meta-analysis and a survey of users
[31, 32].
4. NMES andVitalStiminDysphagia Therapy
While the muscle stimulation units used by physiotherapists
have been utilised in some studies of dysphagic patients
[14, 20], a commercial device, the VitalStim unit, which
was approved for use by the FDA in 2001 speciﬁcally for
dysphagia rehabilitation has featured in the majority of
studies in the literature. The manufacturers of the VitalStim
unit state that on the basis of their FDA submission data,
97.8%–100% of patients treatedwillhave improvement [26].
Research published in 2001 [17] reported that VitalStim
was superior to thermal-tactile stimulation in treating a
group of 99 acute stroke patients, however, this study has
beenwidelycriticisedformethodologicalﬂaws.Despitethese
criticisms, VitalStim has been utilised by several thousand
certiﬁed users in the USA without reports of adverse
eﬀects and with anecdotal reports of signiﬁcant treatment
successes.
Over9,000cliniciansintheUSAhaveundergonetraining
in the use of the VitalStim unit [31]. In 2007, results of
a survey into use of NMES for dysphagia in the USA
were published [32]. Survey respondents reported that
stroke was the most commonly treated cause of dysphagia;
outcomes were generally positive and no treatment-related
complications had occurred following NMES treatment.
Patients were treated in 3–5 sessions per week, usually
for a duration of one-hour and reported above-average
satisfaction with treatment outcomes. Survey respondents
whowerenotusingNMESreportedthattheywereinterested
in the technique but sought published data on outcomes and
safety.
5. Efﬁcacy Data for NMES for
Dysphagia2001–2007
The developer of the VitalStim unit published data that
examined the application of NMES on a group of 63 stroke
patients and compared this to 36 stroke patients treated with
thermal tactile stimulation. The study reported signiﬁcantly
greater improvement in the NMES group, but has been
widely criticised for its many methodological ﬂaws including
use of a nonstandardised rating scale, utilisation of cricopha-
ryngeal dilatation for some patients in the intervention
group, and the use of a therapy technique (thermal tactile
stimulation) that has not been demonstrated as eﬃcacious
[17].
In 2002, Leelamanit et al. published a study exam-
ining the use of NMES on 23 patients with dysphagia
greater than 2 months’ duration. All participants had
dysphagia that was secondary to reduced laryngeal elevation
and were treated with NMES for up to 4 hours daily.
The authors reported that 20 of 23 showed improve-
ment after a short period of “synchronized electrical
stimulation” aimed at improving hyolaryngeal excursion.
Duration of treatment ranged between 2 days to 30
days, with 6 of the 20 patients who demonstrated initial
improvement requiring subsequent treatment due to relapse
[22].
A study comparing VitalStim to “traditional” swallowing
therapy techniques in 2006 reported on 22 subjects with
dysphagiafrommixedaetiologies(includingstrokeandhead
and neck cancer). Participants (n = 11) received VitalStim
and their outcomes were compared to 11 subjects who
received oromotor exercises, compensatory techniques, and
thermal-tactile stimulation. Subjects in both groups demon-
strated change: some improved and some demonstrated
worse outcomes, although 9 of 11 subjects in the VitalStim
group and 10 of 11 subjects in the control group were able
to improve their diet consistencies postintervention. This
study had several methodological shortcomings, including
variability in the number and type of treatment sessions
provided to subjects in the diﬀerent groups, diﬀerence in
time post stroke between commencing treatment and the
small sample sizes [23].
Ludlow and colleagues examined 11 participants with
chronic long standing dysphagia. They were interested in the
eﬀect of NMES on hyoid bone position with (1) no stimu-
lation, (2) low sensory-level stimulation, and (3) maximally
tolerated motor level stimulation when participants were
(a) swallowing and (b) “at rest”. They reported that hyoid
bone depression occurred with stimulation in the “at rest”
condition in 9 of the 11 subjects and hypothesized that this
downward movement of the hyoid would result in increased
incidence of penetration and aspiration. They reported that
no group change in aspiration was seen, in fact, participants
who had the greatest downward hyoid movement with
stimulation at rest had the greatest improvement during
swallowingwiththesamedegreeofstimulation.Theresearch
team also noted improvements in airway protection for the
group when they received low sensory levels of stimulation
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A retrospective analysis of 18 patients of mixed aeti-
ologies treated using NMES reported that 50% of patients
had improvement in their overall dysphagia score (P<
.05); although none of the patients with severe dyspha-
gia were able to discontinue enteral feedings [13]. The
authors noted that the most signiﬁcant gains were made
by patients who were able to consume small amounts
of food orally prior to treatment (n = 7). Following
therapy, 6 of these 7 patients were able to discontinue
tube feeding and two of them regained “normal” swal-
lowing function [25]. The authors stated that NMES “is
clearly a signiﬁcant improvement over existing therapy in
the treatment of dysphagia. Patients generally are very
positive regarding its results,” page 43. It is interesting
that the most signiﬁcant gains in the study occurred
for participants who were able to take small amounts
of oral intake safely; presumably these patients had a
basic swallow pattern established that could be improved
upon by the VitalStim therapy. It should be noted that
deconditioning from reduced muscle use may occur in
dysphagia, with patients who are fed nonorally being
especially susceptible to this phenomenon and report-
ing greater perceived eﬀort in eating; this is particu-
larly true for older patients with decreased functional
reserve [33]. The phenomenon can best be summed up as
“use it or lost it”.
Carnaby-Mann and Crary published results of treatment
of six subjects with chronic dysphagia (ranging from 6
months to 15 years) treated with daily sessions of NMES
to the anterior neck in a controlled experimental con-
dition [26]. One patient withdrew from the study. The
ﬁve patients who completed the study perceived signiﬁcant
improvement in their swallowing ability. Four of the ﬁve
demonstrated clinically signiﬁcant improvement in their
ability. The remaining patient demonstrated improvement
in score, but did not advance in dietary consumption to a
point where this patient met a priori criteria for clinically
meaningful change. Four of the ﬁve patients who completed
the protocol were available for follow up at 6 months
posttreatment: clinical beneﬁts were maintained in these
patients.
In 2007 a meta-analysis of available research into NMES
was published [31]. This noted that although most of
the published studies had reported positive results, many
contained design ﬂaws and threats to external validity
including lack of objective measures of swallowing improve-
ment and lack of controlled trials. A total of seven studies
were included in the meta-analysis, with a total of 255
patients with dysphagia from multiple aetiologies (stroke,
cancer, head trauma, and respiratory failure) and with
m i x e da g ea n dg e n d e r .O n es t u d yh a da9 5 %c o n ﬁ d e n c e
interval that included an eﬀect size of 0, consistent with
no eﬀect being demonstrated, while another had an eﬀect
size close to null. The remaining trials showed eﬀect sizes
over 0.4. Pooled results for the seven studies indicated a
signiﬁcant summary eﬀect size, while analysis of change
in dysphagia rating across the seven studies indicated a
mean improvement of 20% in swallowing performance after
treatment.
6. Effects of NMES on the Normal
SwallowingMechanism
Suiteretal.reportedtheeﬀectofNMESoneightyoungadult
subjects (mean age 27 for males and 25 for females) with
normal swallowing function who received ten 1-hour treat-
ment sessions with the VitalStim device. This study found
no overall signiﬁcant change in myoelectric muscle activity
following treatment, although one subject demonstrated a
large decrease and one a large increase in muscle activity
following NMES. The authors commented that there was a
need to determine optimal intensity of NMES treatment as
higher intensities may be more eﬀective at eliciting muscle
contractions. They also noted that their protocol did not
involve subjects actively swallowing which they conceded
may have accounted for lack of change in myoelectrical
activity [28].
Youngnormalsubjectswithandwithoutelectricalstimu-
lation (at maximum tolerated stimulation levels) were exam-
ined on videoﬂuoroscopy. These normal subjects showed
signiﬁcant hyolaryngeal depression with stimulation at rest,
with reduced hyolaryngeal elevation during swallowing of a
5mL bolus. Swallows that occurred with stimulation were
judged to be “less safe” than swallows without stimulation.
The authors warned that because stimulation reduced hyola-
ryngealexcursioninnormalvolunteers,NMESwouldreduce
e l e v a t i o ni nd y s p h a g i at h e r a p y[ 29]. Diﬀerences in hyoid
bonemovementbetweenyoungerandoldersubjectswithout
dysphagia have been reported in the literature, with hyoid
elevating more slowly and remaining maximally elevated for
a shorter duration in older subjects; however, the hyoid is
noted to elevate farther, particularly for small bolus sizes
[34].
7. CriticismsRegarding Use of NMES in
Dysphagia Therapy
Logemann (2007) criticised VitalStim as it gave some
clinicians an “easy out” from understanding a patient’s
underlying swallow physiology and stated that it had led to
a large potential market “...for desperate patients willing to
try anything”, page 11, and called for much more research
to determine whether NMES has a role to play in the
management of oropharyngeal swallowing disorders [35].
The New Zealand Speech-Language Therapists’ Associ-
ation published a position paper in 2007 that reviewed the
literature on neuromuscular electrical stimulation published
up to 2007. In its conclusion, the paper states “There is pre-
liminary evidence that application of neuromuscular electri-
cal stimulation in swallowing rehabilitation may ultimately
present as a viable approach for swallowing impairment
under some limited condition, however this information is
not yet conﬁrmed. Based on available published literature
and the ethical guidelines that govern clinical practice, it
is thus the position of the New Zealand Speech-Language
Therapists Association that application of this treatment
modality in swallowing rehabilitation cannot be supported
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cause harm and does not meet the expectations for evidence-
based practice. Application of this technique in the patient
populationisconsideredprematureandshouldthereforenot
be utilized in the treatment of swallowing disorders until
further evidence is available” [36].
Speech Pathology Australia produced a position state-
ment in 2008 based on literature published to 2007 which
stated “The current literature does not adequately address
the beneﬁts of the procedure nor its potential harm or long
term eﬀects”, page 3 [37]. A review article discussing NMES
research published up to 2007 concluded that studies have
provided promising ﬁndings, yet there is a need for higher
quality controlled trials to provide evidence of the eﬃcacy of
NMES [38]. Since the Associations produced those papers,
several new studies have been published; these are reviewed
below.
8. Research Published Since2007 on
the Use of NMES to AlleviateDysphagia
Resulting from Stroke
Several European centres were involved in conducting a ran-
domisedtrialof25patientswithdysphagiathathadpersisted
for more than 3 months following a hemispheric stroke
B¨ ulow et al. 2008 [18]. Twelve patients received NMES for
one hour daily 5 days per week for 3 weeks. Thirteen patients
underwent traditional swallowing therapy techniques of
dietary modiﬁcations, positional techniques, or exercises
to improve swallow function. Both groups demonstrated
improvementposttreatment,leadingtheauthorstoconclude
that “swallowing treatment will improve the awareness of
how to eat and drink”, page 308. The authors cautioned
that subjects’ subjective feelings of improvement did not
correlate with objective measures taken on videoﬂuoroscopy,
reporting that two subjects who received NMES required
treatment for aspiration pneumonia after feeling that their
swallowing diﬃculties had resolved and resuming normal
diet and ﬂuid intake.
In Thailand a single blind-controlled study on stroke
patients with dysphagia persisting more than two weeks was
reported, with 28 patients randomised to receive NMES (n =
15)orrehabilitationswallowingtreatment(n = 13).Twenty-
three patients completed the protocol and 21/23 patients
demonstrated some improvement from pre- to posttherapy.
Patients randomised to receive NMES had a signiﬁcantly
(P<. 001) higher gain in their scores on the Functional
Oral Intake Scale (FOIS), a 7-point ordinal scale that reﬂects
the patient’s ability to tolerate diet and ﬂuids safely [19].
The mean duration post stroke was 23.18 (±6.68 days) and
24.09(±6.61days)intherehabilitationversusNMESgroups.
While it can be argued that spontaneous recovery may be
responsible for the changes seen in this study, the majority
of patients who regain swallow function quickly post stroke
tend to have this occur in the ﬁrst two weeks [39, 40].
Lim et al. (2009) reported on 28 Korean stroke patients
randomised to receive NMES plus thermal-tactile stimula-
tion (n = 16) versus thermal-tactile stimulation (TTS) alone
(n = 12). Six of 12 patients in the NMES group who were
tube-fed were able to progress to oral feeding, compared
to 1 of 7 in the TTS group. Other swallowing parameters
(pharyngeal transit time, penetration and aspiration scores)
and patient satisfaction ratings showed greater improvement
in the NMES plus TTS condition compared to TTS alone.
Unfortunately,theauthorsdidnotprovidefollow-upoftheir
subjects, so it is unknown whether treatment gains were
maintained [21].
Park et al. (2009) conducted a study into muscle activity
that examined the eﬀect of stimulation combined with
a swallowing rehabilitation exercise over a period of two
weeks of NMES with intensity set just above the sensory
threshold. They found an increase in peak amplitude of
sEMG immediately following treatment in six of eight
subjects, but responses were not statistically signiﬁcant.
They also reported increased elevation of the hyoid bone
followingNMEStherapy.Forbothpeakamplitudeandhyoid
movement, subjects returned to baseline levels two weeks
following treatment. Their study was conducted on young,
healthy volunteers and the authors concede the diﬃculty in
extrapolating their ﬁndings to dysphagic subjects [30].
Gallas et al. (2009) recruited 11 patients with chronic
dysphagiaasaresultofstroke(hemispheric(n = 7) orbrain-
stem (n = 4)) and treated them with electrical stimulation
for 1 hour per day over 5 days. They reported improvement
in overall swallowing function and decreased nutritional and
respiratory consequences (P<. 01). When evaluated using
transcranialmagneticstimulation,motorcorticalexcitability
and cortical mapping showed no modiﬁcation following the
electrical stimulation [20]. This is similar to the ﬁndings
[35] examining the impact of NMES on hand function in
strokepatients.ThisstudyfoundthatNMESperformedinan
intensive manner (3–6 hours/day for 10 days over a 3-week
period) produced signiﬁcant improvements in functional
activities but did not result in a change in number of voxels
in any neuroanatomical area. Kimberley et al. have also
noted that NMES has been seen to demonstrate the greatest
amount of change in mild-to-moderately impaired subjects
[41]. This may indicate that NMES has the greatest eﬀect
on muscles that have some volitional movement, where
a response can be patterned in focused, intensive therapy
eﬀorts.
9. FutureDirections
T h e r ei sag r e a ti n t e r e s ti nN M E Si nA u s t r a l i aa n dt h e r ea r e
currently a handful Australian Speech Pathologists who have
undergone VitalStim certiﬁcation. Some of these therapists
are oﬀering NMES treatment to patients in adult and
paediatric settings.Itsuseiscurrentlyquitelimited, however,
with therapists constrained to using it in a research context
by the Speech Pathology Australia Position Statement.
Many of the studies that have been published into NMES
have had small numbers and contained methodological
ﬂaws, been conducted on subjects with normal swallow
function, or participants have been of a much younger age
than the populations who experience the highest prevalence
of dysphagia. Criticisms of the available studies have noted
that there is investigator bias, lack of systematic applicationStroke Research and Treatment 5
of techniques, lack of blinding, and many of the scoring
systems that have been utilised as outcome measures have
lacked validity and objectivity. There is also the question
of relapse: many studies have failed to include a follow-up
period that addresses whether patients will experience loss
of function once the NMES therapy is withdrawn. However,
despite these ﬂaws, NMES seems to have some promise in
the treatment of neurogenic dysphagia. Logemann suggested
that in the rush to embrace a new treatment technique,
proper scientiﬁc evaluation studies had been ignored. She
commented that in order for a new technique to be intro-
duced, there should be strong underlying neurophysiologic
rationale for its application to an aetiology, followed by small
group studies to deﬁne the eﬃcacy of the procedure in a
homogenous population. There should then be a move to
studies of several larger groups with diﬀerent diagnoses and
ﬁnally randomised clinical trials should be conducted [35].
There is a good theoretical basis to support the use of
NMES as an adjunctive therapy in dysphagia. The present
data, upon which current guidelines are based, have many
ﬂaws, and there would appear to be a great need for further
well-designed studies to accurately determine the safety
and eﬃcacy of this technique, the populations in whom
it is most eﬃcacious, and the most eﬀective regime of
treatment needed to produce and maintain results. It may
be that the time has come to reexamine whether NMES is
a useful adjunct to current dysphagia therapies, particularly
in those patients with mild-to-moderate impairment whose
swallowing diﬃculties have lasted longer than the ﬁrst two
weeks post-acute insult. This could take the form of an RCT
if several stroke centres were prepared to contribute data in a
collaborativestudy.Theestablishmentofcollaborativestroke
networks in Australia paves the way for this. It is time now
for clinicians with an interest in using NMES for dysphagia
therapy to come together to further discuss a multicentre
research trial.
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